 |
 |
 |
 |
 |
 |
 |
 |
 |
NEWS & ANNOUNCEMENTS | PRESENTATIONS | INDEPENDENT EXPERT'S REPORT | EXPLANATORY MEMORANDUM
TECHNICAL REPORT | PATENT REPORT | INDEPENDENT ACCOUNTANT'S REPORT | E-LIST SUBSCRIBE/UNSUBSCRIBE
| |||||||
| |||||||
| |||||||
NEWS & ANNOUNCEMENTS | PRESENTATIONS | INDEPENDENT EXPERT'S REPORT | EXPLANATORY MEMORANDUM | |||||||
| |||||||
|
TECHNICAL REPORT | PATENT REPORT | INDEPENDENT ACCOUNTANT'S REPORT | E-LIST SUBSCRIBE/UNSUBSCRIBE | |||||||
| |||||||
|
|
Announcements (To December 31st, 2004) Success : Pre-Clinical Trials New "SAC"
Members Bone Medical Chairman Report. Mr.
Perrott Appendix
3Z ASX Announcement 01/12/04 ASX Announcement 23/11/04 ASX Announcement 04/11/04 Bone Medical Secures $250,000 Directors Note Arthritis Research Update Positive Phase I/IIa Clinical Trial on
Oral Osteoporosis Drug ASX Announcement 8/09/2004 Change in Company
Secretary / Registered Office Bone completes phase one human trial Biopharmaceutical
development company Bone Ltd said it has successfully completed the human
phase one component for its oral calcitonin product, BN002. Bone lists on ASX BIOPHARMACEUTICAL
development company Bone Medical Limited (ASX: BNE) today made its debut
on the Australian Stock Exchange. Bone strikes elite research alliance ahead of ASX listing Bone Medical Limited
is pleased to announce it has entered into a Collaborative Testing
Agreement with the Institute of Bone and Joint Research
(IBJR)
Reports
Bone Medical Limited Annual Report Annual Report 2004
Media Bone to Battle Arthritis Elicia Kennedy The West
Australian Company Newsletters Bone November 2004 Chairman Letter Bone May 2004 Newsletter |